Nitto Avecia
Mark Jurras currently serves as a Process/Project Engineer II at Nitto Denko Avecia Inc. since October 2019. Previously, Mark gained valuable experience as a Chemical Engineering Intern at GE Healthcare, focusing on gold plating wastewater analysis and developing an inventory management database. Additional internship roles include a Manufacturing Engineer Intern at Dyno Nobel and a Summer Intern position at the same company. Mark holds a degree from Rensselaer Polytechnic Institute, earned between 2015 and 2019.
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.